Dexcom
Luiz Fernando Bimbatti Mattos is an accomplished professional with extensive experience in corporate strategy, mergers and acquisitions, and legal affairs. Currently serving as Manager of Corporate Strategy at Encore Capital Group, Luiz crafts strategic roadmaps and spearheads initiatives for market diversification. Previous roles include Senior Analyst of Strategy & Corporate Development at NuVasive and M&A Consultant at Ethos Veterinary Health, where Luiz played a significant role in evaluating and executing global M&A opportunities. Luiz has also held leadership positions in legal and financial affairs and has a strong educational background with degrees in Law, Accounting and Finance, and Business Management from various institutions, including Thomas Jefferson School of Law and Pontifícia Universidade Católica de São Paulo.
This person is not in any teams
Dexcom
43 followers
Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes.